Product logins

Find logins to all Clarivate products below.


Cardiac Rhythm Management Devices – Market Insights – Latin America (Supplemental)

The Latin American CRM device market will be driven by the expanding patient pool and improving access to treatment in Latin American countries. The market will experience modest growth through 2032, fueled by increasing adoption of premium-priced device, such as leadless pacemakers and S-ICDs. However, ASP declines due to the increasing competition will somewhat limit market revenues.

This Medtech 360 Report provides comprehensive data and analysis on the state of the Latin American CRM device market from 2019 through 2032.

Table of contents


Related Medtech Insights Reports

Report
Vascular Closure Devices – Market Insights – Global
The global VCD market will grow moderately, driven primarily by increasing endovascular interventional procedure volumes and by innovation associated with new products entering the market. Growth…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Cardiac Rhythm Management Devices – Market Insights – United States
The US CRM device market is expected to grow rapidly through 2034, driven by the increasing adoption of innovative devices, such as dual-chamber leadless pacemakers and extravascular ICDs. These…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Neurovascular Devices – Market Insights – Latin America
The Latin American neurovascular device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing…